TRCT
OGN icon

Tower Research Capital (TRC)’s Organon & Co OGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.2K Buy
5,408
+226
+4% +$2.7K ﹤0.01% 2440
2026
Q1 		$31K Sell
5,182
-853
-14% -$6.42K ﹤0.01% 3141
2025
Q4 		$43.3K Buy
6,035
+4,363
+261% +$34.5K ﹤0.01% 2533
2025
Q3 		$17.9K Buy
1,672
+12
+0.7% +$118 ﹤0.01% 3410
2025
Q2 		$16.1K Buy
1,660
+500
+43% +$5.16K ﹤0.01% 3797
2025
Q1 		$17.3K Sell
1,160
-8,651
-88% -$133K ﹤0.01% 3114
2024
Q4 		$146K Buy
9,811
+142
+1% +$2.31K ﹤0.01% 1915
2024
Q3 		$185K Buy
9,669
+7,944
+461% +$165K ﹤0.01% 1697
2024
Q2 		$35.7K Sell
1,725
-3,548
-67% -$70.5K ﹤0.01% 3357
2024
Q1 		$99.1K Sell
5,273
-7,098
-57% -$122K ﹤0.01% 1823
2023
Q4 		$178K Sell
12,371
-14,531
-54% -$198K ﹤0.01% 2194
2023
Q3 		$467K Buy
26,902
+15,788
+142% +$329K 0.01% 906
2023
Q2 		$231K Buy
11,114
+8,187
+280% +$178K 0.01% 1455
2023
Q1 		$69K Sell
2,927
-1,565
-35% -$42K ﹤0.01% 2211
2022
Q4 		$126K Sell
4,492
-49,647
-92% -$1.27M 0.01% 1647
2022
Q3 		$1.27M Buy
54,139
+39,261
+264% +$1.19M 0.02% 596
2022
Q2 		$502K Sell
14,878
-20,793
-58% -$728K 0.01% 1132
2022
Q1 		$1.25M Buy
35,671
+20,217
+131% +$691K 0.01% 710
2021
Q4 		$471K Buy
15,454
+4,736
+44% +$154K 0.01% 1156
2021
Q3 		$351K Sell
10,718
-7,570
-41% -$242K 0.01% 1254
2021
Q2 		$554K Buy
+18,288
New +$602K 0.01% 1102

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Tower Research Capital (TRC)'s OGN Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Organon & Co (OGN) stake by 4.4% in Q2 2026, buying an estimated $2.7K and bringing the position to 5,408 shares worth $73.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2440.

Tower Research Capital (TRC) first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.27M in Q3 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Tower Research Capital (TRC) held 5,408 shares of Organon & Co worth $73.2K as of Q2 2026.
  • Tower Research Capital (TRC) bought 226 Organon & Co shares in Q2 2026, an estimated $2.7K.
  • Organon & Co made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2440 holding.
  • Tower Research Capital (TRC) first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Organon & Co position peaked at $1.27M in Q3 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.